BOSTON, Feb. 28,
2024 /PRNewswire/ -- Elevation Oncology, Inc.
(Nasdaq: ELEV), an innovative oncology company focused on the
discovery and development of selective cancer therapies to treat
patients across a range of solid tumors with significant unmet
medical needs, today announced that members of management will
participate in upcoming investor conferences in March:
- TD Cowen 44th Annual Health Care
Conference. Fireside chat on Wednesday, March 6, 2024 at 10:30 AM ET in Boston,
MA.
- Leerink Global Biopharma Conference. Management
will participate in investor meetings on Tuesday, March 12, 2024 in Miami, FL.
A live webcast and replay of the fireside chat at the TD Cowen
44th Annual Health Care Conference will be available on
the Events page of the Company's Investor Relations website at
https://investors.elevationoncology.com.
About Elevation Oncology, Inc.
Elevation Oncology is an innovative oncology company focused on
the discovery and development of selective cancer therapies to
treat patients across a range of solid tumors with significant
unmet medical needs. We are rethinking drug development by seeking
out innovative, selective cancer therapies that can be matched to a
patient's unique tumor characteristics. Our lead candidate,
EO-3021, is a potential best-in-class antibody drug conjugate (ADC)
designed to target Claudin 18.2, a clinically validated molecular
target. EO-3021 selectively delivers a cytotoxic payload directly
to cancer cells expressing Claudin 18.2. We are evaluating EO-3021
in a Phase 1 study in patients with advanced, unresectable or
metastatic solid tumors likely to express Claudin 18.2 including
gastric, gastroesophageal junction, pancreatic or esophageal
cancers. We are also exploring other opportunities through new or
existing partnerships and business development opportunities to
expand our oncology pipeline. For more information, visit
www.ElevationOncology.com.
Elevation Oncology Investor and Media Contact
Candice Masse, 978-879-7273
Senior Director, Corporate Communications & Investor
Relations
cmasse@elevationoncology.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/elevation-oncology-to-participate-in-upcoming-investor-conferences-302069619.html
SOURCE Elevation Oncology